< Back to previous page

Project

Repurposing lung surfactant protein B for inhalation therapy with RNA therapeutics

RNA therapeutics, including small interfering RNA (siRNA) and messenger RNA (mRNA), are poised to revolutionize medicine. However, despite a clear unmet medical need in many lung diseases, no RNA formulations are currently available for pulmonary use. To unlock the full therapeutic potential of RNA, safe and efficient nanocarriers that can deliver them inside target cells are required. This project aims to develop inhalable nanoformulations for RNA therapeutics, including the repurposing of lung surfactant to promote the cytosolic delivery of RNA in lung-related target cells.

Date:1 Nov 2020 →  Today
Keywords:lipid nanoparticles, inhalation therapy, RNA therapeutics
Disciplines:Respiratory medicine, Biopharmaceuticals, Biopharmaceutics, Biomaterials, Gene and molecular therapy